KR100454226B1 - Processing method of licorice extract and its' utilization on developing anti-cariogenic products - Google Patents
Processing method of licorice extract and its' utilization on developing anti-cariogenic products Download PDFInfo
- Publication number
- KR100454226B1 KR100454226B1 KR10-2001-0000653A KR20010000653A KR100454226B1 KR 100454226 B1 KR100454226 B1 KR 100454226B1 KR 20010000653 A KR20010000653 A KR 20010000653A KR 100454226 B1 KR100454226 B1 KR 100454226B1
- Authority
- KR
- South Korea
- Prior art keywords
- licorice
- licorice extract
- extract
- hours
- hot water
- Prior art date
Links
- 229940069445 licorice extract Drugs 0.000 title claims abstract description 48
- 230000000170 anti-cariogenic effect Effects 0.000 title description 2
- 238000003672 processing method Methods 0.000 title 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 42
- 241000202807 Glycyrrhiza Species 0.000 claims abstract description 41
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 41
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 41
- 229940010454 licorice Drugs 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 235000009508 confectionery Nutrition 0.000 claims abstract description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 10
- 239000000606 toothpaste Substances 0.000 claims abstract description 8
- 229940034610 toothpaste Drugs 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 230000002829 reductive effect Effects 0.000 claims abstract description 6
- 238000007602 hot air drying Methods 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 235000015218 chewing gum Nutrition 0.000 claims abstract 2
- 229940112822 chewing gum Drugs 0.000 claims abstract 2
- 238000004108 freeze drying Methods 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims description 18
- 108010043797 4-alpha-glucanotransferase Proteins 0.000 claims description 14
- 102100039604 mRNA guanylyltransferase Human genes 0.000 claims description 14
- 108010026228 mRNA guanylyltransferase Proteins 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 4
- 239000001814 pectin Substances 0.000 claims description 4
- 235000010987 pectin Nutrition 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 208000002925 dental caries Diseases 0.000 abstract description 21
- 239000003960 organic solvent Substances 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 7
- 241000194019 Streptococcus mutans Species 0.000 description 17
- 230000002401 inhibitory effect Effects 0.000 description 13
- 239000011797 cavity material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000001848 glycyrrhiza glabra l. root extract powder Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000009036 growth inhibition Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000009422 growth inhibiting effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 108700033546 Aspergillus terreus M3328 Mutastein Proteins 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002032 methanolic fraction Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/04—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing vitamins, antibiotics, other medicaments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/312—Foods, ingredients or supplements having a functional effect on health having an effect on dental health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 감초추출물의 제조방법 및 감초추출물을 함유한 기능성 항충치 물질에 관한 것이다.The present invention relates to a method for preparing licorice extract and a functional anti-cardium substance containing licorice extract.
본 발명의 감초추출물의 제조방법은 감초와 감초무게 10∼30배의 물을 혼합하여 40∼150℃의 온도에서 10분∼3시간 동안 3∼5회 열수 추출하는 단계와; 열수 추출한 감초를 여과하여 감초의 감미성분을 제거하는 단계와; 여과 후 남은 감초의 잔사에 잔사무게 5∼30배의 유기용매를 가하여 30∼100℃의 온도에서 10분∼4시간 동안 감압하에서 추출한 후 여과하는 단계와; 상기 단계 후 잔사무게의 1∼100%의 부형제를 첨가하여 농축 후 동결건조 또는 열풍건조하는 단계를 포함하는 것을 특징으로 한다.Licorice extract manufacturing method of the present invention comprises the steps of mixing the licorice and licorice weight 10 to 30 times the water and extracting hot water 3 to 5 times for 10 minutes to 3 hours at a temperature of 40 ~ 150 ℃; Filtering the hot water extracted licorice to remove sweet components of licorice; Adding a 5-30-fold organic solvent to the residue of licorice remaining after filtration, and extracting under reduced pressure for 10 minutes to 4 hours at a temperature of 30 to 100 ℃ and filtration; After the step, it is characterized in that it comprises a step of lyophilization or hot air drying after the concentration by adding an excipient of 1 to 100% of the fine office crab.
본 발명은 상기와 같이 감초추출물을 제조하고 이 감초추출물을 유효성분으로 함유한 치약, 껌 또는 사탕을 제공함으로써 치아우식(충치)을 억제할 수 있는 물질의 제공을 목적으로 한다.An object of the present invention is to provide a substance which can suppress tooth caries (cavities) by preparing a licorice extract and providing a toothpaste, chewing gum or candy containing the licorice extract as an active ingredient.
Description
본 발명은 감초추출물의 제조방법 및 감초추출물을 함유한 기능성 항충치 물질에 관한 것으로서 보다 상세하게는 감초를 열수추출한 후 부형제를 첨가하고 유기용매로 추출하는 단계를 포함하는 감초추출물의 제조방법 및 상기 방법에 의해 추출된 감초추출물을 치약, 껌 또는 사탕에 함유된 항충치 물질에 관한 것이다.The present invention relates to a method for preparing licorice extract and a functional anti-caustic substance containing licorice extract, and more particularly, a method for preparing licorice extract comprising extracting hot liquor from a licorice extract and adding an excipient and extracting it with an organic solvent. The licorice extract extracted by the method relates to an anti-cardium substance contained in toothpaste, gum or candy.
식생활 형태가 점차 다양해짐에 따라 당류의 소비는 증가추세에 있는 반면 스트레스 및 질병에 의해 인체내 면역기능이 약화되고 있으며 특히 구강내 미생물이 증가추세에 있다.As dietary patterns are gradually diversified, consumption of sugars is on the rise, while immune function in the human body is weakened by stress and disease, and in particular, oral microorganisms are on the rise.
대한치과의사협회의 조사(1992년)에 의하면 우리나라 아동의 90% 이상이 치아우식(dental caries, 일명 충치)을 경험했으며 성인 80% 이상이 잇몸병을 갖고 있다고 보고하고 있다.According to a survey by the Korean Dental Association (1992), more than 90% of Korean children have experienced dental caries (aka tooth decay) and 80% of adults have gum disease.
충치는 구강내 미생물 중 특히 스트렙토코커스 뮤탄스(Streptococcus mutans) 균이 주요 원인이 되어 치아중 무기질이 탈회되고 상아질이 파괴되어 치아조직의 결손을 초래하는 세균성 치아 경조직 질환이다.Tooth decay is a bacterial dental hard tissue disease in which microorganisms in the oral cavity, in particular Streptococcus mutans , are the main cause of demineralization of minerals in teeth and destruction of dentin, leading to defects in dental tissues.
먼저 인간의 충치발생원인을 간단히 살펴보면, 충치는 치아, 뮤탄스(mutans) 연쇄상구균, 탄수화물의 3가지 조건이 존재할 때 발생한다. 스트렙토코커스 뮤탄스(분리균의 약 80%)와 스트렙토코커스 소르비터스(S. sorbitus)(약 20%) 등의 뮤탄스균은 효율적인 에너지원인 수크로즈(sucrose)를 분해하여 생육에 이용한 후유산을 주로 하는 유기산을 생성한다. 이들 유기산의 작용에 의해 치아의 에나멜질의 화학성분인 히드록시아파티트(hydroxyapatite, Ca10(PO4)6(OH)2)가 분해되며 이것을 탈회(decalcification)라 한다First of all, the cause of human caries is briefly described. Tooth decay occurs when three conditions exist: tooth, mutans streptococci and carbohydrates. Mutans such as Streptococcus mutans (about 80% of isolates) and Streptococcus sorbitus (about 20%) decompose sucrose, an efficient energy source, to use post-lactic acid used for growth. Produces an organic acid that is mainly used. By the action of these organic acids, hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), which is a tooth enamel chemical, is decomposed. This is called decalcification.
또한 뮤탄스균은 수크로즈를 기질로 해서 글루코스(glucose)와 프럭토스(fructose)를 생성하고 이들 중 생성된 글루코스는 글루코실트랜스퍼라제 (glucosyltransferase, 이하 GTase 으로 약칭함)의 작용을 받아 불용성의 글루칸(glucan)을 치아표면에 형성하게 된다. 치아표면에 부착된 불용성 글루칸에 충치균 등이 부착되게 되며 이렇게 형성된 미생물의 부착집단을 플라그(plaque)라 한다. 따라서 효과적인 항충치 작용은 충치균이 이용하지 못하는 수크로즈 대체 감미료 사용, 불용성 글루칸을 분해 또는 용해시키는 소재, 불용성 글루칸의 합성을 저해시킬 수 있도록 GTase의 활성을 저하시킬 수 있는 소재 또는 충치균의 증식을 억제시키는 기능을 가진 소재를 발굴할 수 있으면 가능할 것이다.In addition, mutans produces glucose and fructose using sucrose as a substrate, and glucose produced from these is insoluble glucan (hereinafter referred to as glucosyltransferase). Glucan is formed on the tooth surface. Tooth decay bacteria and the like are attached to the insoluble glucan attached to the tooth surface, and the attachment group of the microorganisms thus formed is called plaque. Therefore, the effective anti-cavities can inhibit the use of sucrose substitute sweeteners that are not available to cavities, materials that break down or dissolve insoluble glucans, and inhibit the growth of cavities or materials that can lower the activity of GTase to inhibit the synthesis of insoluble glucans. If you can find a material with a function to make it possible.
치아우식에 대한 통계비교치는 12세 아동의 우식경험영구치수(DMFT index) 즉 12살 아동이 영구치에 평균 몇 개 정도가 우식을 경험했는가에 대한 지수로 나타내는데 우리나라의 경우는 1980년대 초반 2.0, 1980년대 후반 2.5, 1990년대 초반 3.0으로 지난 20년 동안 우리나라 아동에 있어서 치아우식 발생은 계속 급진적으로 증가돼 왔다. 일본은 현재 4.7∼4.9로 보고되어 있으며 미국의 경우에는 1960년 7.6, 1976년 5.8, 1979년 4.0, 1986년 3.1, 1987년 2.68로 미국에서는 충치가 점차적으로 줄어들고 있는 경향이다.The statistical comparison of dental caries is expressed by the DMFT index of 12-year-old children, which is an index of the average number of caries experienced by 12-year-old children in permanent teeth. In the late 20's, 2.5's in the early 1990's and 3.0 in the early 1990's, the rate of dental caries in Korean children has increased dramatically. Japan is currently reported to be 4.7 to 4.9. In the United States, tooth decay is gradually decreasing in the United States to 7.6 in 1960, 5.8 in 1976, 4.0 in 1979, 3.1 in 1986 and 2.68 in 1987.
지금까지의 식품관련 항충치에 관한 연구는 주로 뮤탄스균이 용이하게 이용하지 못하는 수크로즈를 대체하는 감미료에 관한 것이 주류를 이루고 있으며 그 외에 천연물질로부터 항우식균 작용을 가진 물질의 분리 등이 연구되고 있다. 대체감미료 중 특히 팔라티노즈(palatinose)는 GTase의 활성을 강력히 억제하여 플라그(plaque)의 형성을 저해한다고 보고되었다. 녹차 및 우롱차 중의 카테친(catechin ) 등이 GTase에 대해 강력한 저해활성을 갖는 것으로 확인되었으며 토양에서 분리한 곰팡이인 아스퍼질러스 테레우스(Aspergillus terreus)의 배양액으로부터 무타스테인(mutastein)이라는 당단백질이 분리되어 GTase 저해작용을 갖는 것으로 보고되었다. 또한 스트렙토코커스 뮤탄스(S. mutans)의 항체(antibody)를 계란의 IgY로부터 얻어 항충치균 효과를 식품에 직접 적용해 보려는 시도도 있었다. 그러나 대부분 상품화에 이르지 못하고 있으며 산업적으로 응용가치를 지닌 항충치 소재의 개발이 미흡한 실정이다.Until now, research on food-related anti tooth decay has mainly focused on sweeteners that replace sucrose, which is not easily used by mutans bacteria, and the separation of substances having anti-cartococcus activity from natural substances. have. Among alternative sweeteners, especially palatinose, has been reported to inhibit the formation of plaque by strongly inhibiting the activity of GTase. The catechins in green tea and oolong tea have been shown to have potent inhibitory activity against GTase, and the glycoprotein called mutastein is isolated from the culture of Aspergillus terreus, a fungus isolated from soil. Has been reported to have GTase inhibitory activity. Attempts have also been made to obtain antiseptic bacteria directly from food by obtaining antibodies from S. mutans from the IgY of eggs. However, most of them have not been commercialized and the development of anti-cavity materials with industrial value is insufficient.
이에 본 발명자들은 효과적인 항충치 작용을 위한 충치균의 생육억제와 GTase의 활성을 저하시킬 수 있는 소재를 찾기 위해 노력하던 중 감초를 열수추출하여 감초의 감미성분을 제거한 감초 잔사를 유기용매로 추출한 후 부형제를 첨가하여 농축시킨 감초추출물이 충치균의 생육을 억제하고 GTase의 활성을 저하시킬 수 있음을 알게 되었다. 따라서 본 발명은 상기와 같이 감초추출물을 제조하고 이 감초추출물을 유효성분으로 함유한 치약, 껌 또는 사탕을 제공함으로써 치아우식(충치)을 억제할 수 있는 물질의 제공을 목적으로 한다.Therefore, the present inventors tried to find a material that can inhibit the growth of cavities and decrease GTase activity for effective anti-cavities, and extract licorice residues from the licorice by extracting the licorice components with organic solvent after excipients. Concentrated licorice extract was found to inhibit the growth of caries and reduce the activity of GTase. Accordingly, an object of the present invention is to provide a substance which can suppress tooth caries (cavities) by preparing a licorice extract as described above and providing a toothpaste, gum or candy containing the licorice extract as an active ingredient.
도 1은 본 발명의 감초추출물의 제조공정도이다.1 is a manufacturing process of the licorice extract of the present invention.
도 2는 본 발명의 감초추출물의 실리카겔 컬럼 크로마토그래피이다.Figure 2 is a silica gel column chromatography of the licorice extract of the present invention.
도 3은 도 2의 각 분획을 HPLC상에서 비교한 HPLC 크로마토그래피이다.FIG. 3 is HPLC chromatography comparing each fraction of FIG. 2 on HPLC.
도 4는 본 발명의 감초추출물을 치약에 사용시 충치균에 대한 생육저해를 나타낸 사진이다(맨 위에서부터 시계방향으로 control, 무첨가군, 0.025% 감초추출물 첨가군, 0.05% 감초추출물 첨가군, 0.1% 감초추출물 첨가군).Figure 4 is a photograph showing the growth inhibition against caries bacteria when the licorice extract of the present invention is used in toothpaste (control, no addition, 0.025% licorice extract group, 0.05% licorice extract group, 0.1% licorice from the top clockwise) Extract addition group).
도 5는 본 발명의 감초추출물을 껌에 사용시 충치균에 대한 생육저해를 나타낸 사진이다(맨 위에서부터 시계방향으로 control, 무첨가구, 1.0% 감초추출물 첨가군, 3.0% 감초추출물 첨가군, 2.0% 감초추출물 첨가군).Figure 5 is a photograph showing the growth inhibition against caries bacteria when the licorice extract of the present invention is used in gum (control, no addition, 1.0% licorice extract group, 3.0% licorice extract group, 2.0% licorice from the top clockwise) Extract addition group).
본 발명의 감초추출물의 제조방법은 도 1과 같이 감초와 감초무게 10∼30배의 물을 혼합하여 40∼150℃의 온도에서 10분∼3시간 시간동안 3∼5회 열수 추출하는 단계와;Licorice extract manufacturing method of the present invention comprises the steps of mixing the licorice and licorice weight 10 to 30 times water as shown in Figure 1 3 to 5 times hot water extraction for 10 minutes to 3 hours at a temperature of 40 ~ 150 ℃;
열수 추출한 감초를 여과하여 감초의 감미성분을 제거하는 단계와;Filtering the hot water extracted licorice to remove sweet components of licorice;
여과 후 남은 감초의 잔사에 감초 잔사무게 5∼30배의 유기용매를 가하여 30∼100℃의 온도에서 10분∼4시간 동안 감압하에서 추출하여 여과하는 단계와;Adding an organic solvent of licorice residues 5-30 times to the residue of licorice remaining after filtration and extracting and filtering under reduced pressure for 10 minutes to 4 hours at a temperature of 30 to 100 캜;
상기 단계 후 감초 잔사무게 1∼20%의 부형제를 첨가하여 추출물을 농축 후 -50 ∼ -40℃의 온도, 15∼30 Torr에서 2∼4일간 동결건조 또는 일반적인 방법으로 열풍건조하는 단계를 포함하는 것을 특징으로 한다. 한편 상기의 방법에 의해 제조한 감초추출물을 유효성분으로 함유한 치약, 껌 또는 사탕의 항충치 물질을 제공할 수 있다.Concentrating the extract by adding an excipient of 1-20% licorice crab after the above step and then lyophilizing or hot-air drying in a general manner for 2-4 days at a temperature of -50 to -40 ℃, 15-30 Torr It is characterized by. On the other hand, it is possible to provide an anti tooth decay material of toothpaste, gum or candy containing licorice extract prepared by the above method as an active ingredient.
상기에서 물은 감초무게에 대하여 10배 미만 사용시에는 감초가 충분히 물에 잠기지 못하는 문제점이 있고, 30배 초과 사용시에는 감초가 물에 과다하게 희석되어 효율이 저하되는 문제가 있어 물은 감초무게에 대하여 10∼30배를 유지하는 것이 좋다.In the above water, licorice is not sufficiently submerged in water when used less than 10 times with respect to licorice weight, and when it is used in excess of 30 times, licorice is excessively diluted in water, thereby decreasing efficiency. It is good to maintain 10-30 times.
열수추출 단계에서는 여러 가지 방법으로 실험한 바 실험적으로 40∼150℃의 온도에서 10분∼3시간 시간동안 3∼5회 열수 추출시 가장 좋은 감초추출물을 얻을수 있었다.In the hot water extraction step, experiments were carried out with various methods. The best licorice extract was obtained when hot water extraction was carried out 3 to 5 times for 10 minutes to 3 hours at a temperature of 40 to 150 ° C.
유기용매는 에탄올, 메탄올, 부탄올, 프로판올, 에틸아세테이트, 아세톤, 클로로포름, 핵산을을 사용할 수 있으며, 유기용매를 감초 잔사무게 5배 미만 사용시에는 충분한 추출이 이루어지지 못하는 문제점이 있어 좋지 않으며, 유기용매를 감초 잔사무게 30배 초과 사용시에는 추출효율에 대한 차이가 없이 용매의 사용량이 지나치게 과다해져 비용만 증가하는 문제가 있어 유기용매는 감초 잔사무게 5∼30배를 유지하는 것이 좋다.The organic solvent may be ethanol, methanol, butanol, propanol, ethyl acetate, acetone, chloroform, nucleic acid, and when using the organic solvent less than 5 times licorice residue, there is a problem that it is not enough extraction, organic solvent When using more than 30 times of licorice residues, there is a problem that the amount of solvent is excessively increased without increasing the extraction efficiency, so that only the cost increases, and organic solvents should maintain the licorice residues 5 to 30 times.
부형제는 카라기난(Carageenan), 유당, 덱스트린, 싸이크로 덱스트린, 카제인, 펙틴, 산탄검, 또는 펙틴을 사용할 수 있으며, 부형제를 감초 잔사무게 1% 미만 사용시에는 추출물의 물에 대한 용해력 향상에 도움을 줄 수 없어 좋지 않으며 부형제를 감초 잔사무게 100% 초과 사용시에는 추출물의 항충치 효력이 저하되어 부형제는 감초 잔사무게 1∼100%를 유지하는 것이 좋다.Excipients may use Carageenan, lactose, dextrin, cyclodextrin, casein, pectin, xanthan gum, or pectin, and when the excipient is used in less than 1% licorice residue, it will help to improve the solubility of the extract in water. If the excipient is used more than 100% licorice bean curd, the anti-cariogenic effect of the extract is lowered, so the excipient is preferably maintained 1 to 100% licorice bean curd.
이하 본 발명을 다음의 실시예 및 시험예에 의하여 설명하고자 한다. 그러나 이들이 본 발명의 기술적 범위를 한정하는 것은 아니다.Hereinafter, the present invention will be described by the following examples and test examples. However, these do not limit the technical scope of the present invention.
<실시예><Example>
감초 40kg에 800L의 물을 혼합하여 상압, 90℃의 온도에서 2시간 동안 3회 열수 추출하고, 열수 추출한 감초를 여과하여 감초의 감미를 나타내는 단맛성분인 그리시리진(glycyrrhizin)을 완전히 제거하였다. 여과 후 남은 감초의 잔사(감초박)에 유기용매로 감초 잔사무게 15배의 75% 에탄올을 가하여 감압, 85℃의 온도에서 2시간 동안 추출하고 추출물을 여과한 후, 부형제로 감초 잔사무게 10%의 카라기난을 첨가하고 농축하여 페이스트 상태의 추출물을 얻은 후 이를 -50℃, 15 Torr에서 3일간 동결건조하여 분말 상태의 감초추출물을 얻었다.800L of licorice was mixed with 40 kg of licorice and extracted with hot water three times for two hours at a temperature of 90 ° C. under normal pressure, and the hot water extracted licorice was filtered to completely remove glycyrrhizin, which is a sweet component representing sweetness of licorice. After the filtration, the remaining licorice residue (Liquorice thin) was added with 75% ethanol residue of 15 times of licorice with organic solvent and extracted for 2 hours under reduced pressure and 85 ℃. After filtering the extract, 10% of licorice residue with excipient Carrageenan was added and concentrated to obtain an extract in the form of a paste, which was lyophilized for 3 days at -50 ℃, 15 Torr to obtain a licorice extract in the powder state.
<시험예 1><Test Example 1>
상기 실시예에 의해 제조한 감초추출물의 충치균에 대한 항균효과를 측정하기 위하여 스트렙토코커스 뮤탄스(Streptococcus mutans, KFRI 1171, 1172, 1175)를 분양받아 균주로 사용하였으며 증식배지 brain heart infusion broth(BHI broth)에 스트렙토코커스 뮤탄스(Streptococcus mutans, KFRI 1171, 1172, 1175)를 접종하여 37℃ 온도의 회전 인큐베이터(shaking incubator)에서 3회 계대 배양함으로서 균주의 활성을 회복시켰다. 활성이 회복된 균주를 한천평판배지에 분주하여 37℃에서 24시간 배양하여 콜로니(colony)를 확인하였다.In order to measure the antimicrobial effect of the licorice bacteria of the licorice extract prepared by the above Example ( Streptococcus mutans , KFRI 1171, 1172, 1175) was used as a strain and growth medium brain heart infusion broth (BHI broth ) Was inoculated with Streptococcus mutans (KFRI 1171, 1172, 1175) to recover the activity of the strain by three passages in a 37 ° C rotating incubator (shaking incubator). The recovered strains were aliquoted into agar plate medium and incubated at 37 ° C. for 24 hours to identify colonies.
배양균주 0.1㎖와 4∼20 ppm 농도의 감초추출물 0.1㎖를 시험튜브(test tube)에 넣은 것과 감초추출물을 넣지 않은 무첨가군(control)에 대하여 top agar 2.5㎖를 가하여 BHI agar에 부어 굳힌 후 37℃ 인큐베이터에서 24시간 배양한 후 콜로니 수를 측정하여 그 결과를 아래의 표 1에 나타내었다.Add 0.1 ml of the culture strain and 0.1 ml of 4-20 ppm licorice extract to a test tube, and add 2.5 ml of top agar to the BHI agar. After incubating in the incubator for 24 hours, the number of colonies was measured and the results are shown in Table 1 below.
표 1은 감초추출물분말의 농도별 스트렙토코커스 뮤탄스에 대한 항균활성을 나타내고 있다. 동결건조된 감초추출물 분말을 4 ppm 농도로만 첨가하여도 99.6(KFRI 1171) ∼ 64.3%(KFRI 1175)의 스트렙토코커스 뮤탄스 균주의 생육저해효과가 관찰되어 감초추출물분말의 스트렙토코커스 뮤탄스에 대한 최소생육저해농도(Minimal Inhibitory Concentration)는 4 ppm 이하로 추정된다.Table 1 shows the antimicrobial activity against Streptococcus mutans by concentration of licorice extract powder. The growth inhibition of Streptococcus mutans strains of 99.6 (KFRI 1171) to 64.3% (KFRI 1175) was observed even with the addition of lyophilized licorice extract powder at a concentration of 4 ppm, indicating that the licorice extract powder had no effect on Streptococcus mutans. Minimal Inhibitory Concentration is estimated to be 4 ppm or less.
표 1. 감초추출물 분말의 스트렙토코커스 뮤탄스에 대한 항균효과Table 1. Antibacterial Effect of Licorice Extract Powder against Streptococcus Mutans
한편 20 ppm 농도의 감초추출물을 첨가하였을 경우, 스트렙토코커스 뮤탄스 KFRI 1171, KFRI 1172, KFRI 1175균에 대하여 각각 99.9, 99.8, 99.1%의 생육저해효과가 나타났으며, 40 ppm 농도의 감초추출물을 첨가하였을 경우에는 스트렙토코커스 뮤탄스 KFRI 1171, KFRI 1172, KFRI 1175균에 대하여 각각 99.99, 99.94, 99.88%의 생육저해효과를 보였다.On the other hand, when the licorice extract of 20 ppm concentration was added, Streptococcus mutans Growth inhibitory effects of 99.9, 99.8 and 99.1% were observed on KFRI 1171, KFRI 1172, and KFRI 1175, respectively. Streptococcus mutans The inhibitory effect of growth was 99.99, 99.94 and 99.88% against KFRI 1171, KFRI 1172 and KFRI 1175, respectively.
<시험예 2><Test Example 2>
항충치균 효과를 나타내는 원인물질을 분리, 동정하기 위하여 상기 실시예의 방법으로 제조한 감초추출물을 헥산(hexane), 클로로포름(chloroform), 에틸아세테이트(ethylacetate), 부탄올(butanol) 순으로 순차적으로 용매분획을 행하였다. 상기 용매분획 중 항균력이 가장 강한 클로로포름 분획을 실리카겔 컬럼(silicagelcolumn)에 충진(loading)하여 메탄올(methanol) 농도를 0% (CHCl3100%) ∼ 100%로 단계적으로 증가시켜 분획하였을 때, 도 2와 같이 4개의 프랙션(fraction)을 분획하였으며 이들 각 분획의 스트렙토코커스 뮤탄스에 대한 생육저해 효과는 표 2와 같았다.In order to isolate and identify the causative agent exhibiting the anti-cartococcal effect, the licorice extract prepared by the method of the above example was subjected to solvent fractions in the order of hexane, chloroform, ethylacetate and butanol. It was done. When the chloroform fraction having the strongest antibacterial activity among the solvent fractions was loaded into a silica gel column, the methanol fraction was fractionated by increasing the methanol concentration from 0% (CHCl 3 100%) to 100% step by step. Four fractions were fractionated as shown in Table 2 and their inhibitory effects on the Streptococcus mutans were shown in Table 2.
표 2. 실리카겔 컬럼으로부터 얻어진 분획의 스트렙토코커스 뮤탄스에 대한 생육억제 효과Table 2. Growth Inhibitory Effects on Streptococcus Mutans of Fractions Obtained from Silica Gel Columns
*paper disc 직경 = 8.0mm* paper disc diameter = 8.0mm
스트렙토코커스 뮤탄스에 대한 항균력은 분획(I)에서 거의 대부분 나타났으며 HPLC상에서 YMC-Pack column을 이용하여 각 분획의 구성성분을 비교해 본 결과(도 3 참조), 분획(I)에는 다른 분획들에 비해 극성이 낮은 소수성(hydrophobic)의 구성성분이 차지하는 비율이 월등히 높은 것으로 나타나 이들 성분들이 감초 특유의 충치균 생육억제능의 발현에 중요한 역할을 하리라 사료된다.Antimicrobial activity against Streptococcus mutans Almost all of the fractions (I) and the composition of each fraction by using the YMC-Pack column on the HPLC (see Fig. 3), fraction (I) has a low polarity (hydrophobic) compared to the other fractions ), The ratio of constituents is very high, and these components may play an important role in the expression of carcass growth inhibitory ability.
<시험예 3><Test Example 3>
상기 실시예의 방법에 의해 제조한 감초추출물의 GTase 활성저해능력을 조사하여 그 결과를 아래의 표 3에 정리하여 나타내었다.The GTase activity inhibiting ability of the licorice extract prepared by the method of Example was examined and the results are summarized in Table 3 below.
감초추출물의 GTase 활성저해능력은 충치균으로 상기 시험예 1과 같이 배양한 스트렙토코커스 뮤탄스 KFRI 1171, KFRI 1172, KFRI 1175 배양액을 4℃에서 8,000rpm으로 5분간 원심분리시킨 후 그 상등액을 취하여 toyo filter paper No. 101로 여과하고, 그 여액을 1N-NaOH를 이용하여 pH를 7.0으로 조정한 다음 소듐아자이드(sodium azide)를 0.02% 첨가하여 제조한 조효소액에 1% 수크로즈(sucrose)와 감초추출물을 25 ppm, 50 ppm, 100 ppm 농도별로 첨가하고 37℃, 24시간 반응시킨 후 660nm에서 탁도를 측정하여 감초추출물을 첨가하지 않은 무첨가군과 비교한 상대치로 글루칸(glucan) 생성 억제 정도를 측정하여 GTase 활성 억제 효과를 비교하였다.GTase activity inhibiting ability of the licorice extract is Streptococcus mutans incubated in the same way as Test Example 1 KFRI 1171, KFRI 1172, and KFRI 1175 cultures were centrifuged at 8,000 rpm for 5 minutes at 4 ° C. Filtered to 101, the filtrate was adjusted to pH 7.0 using 1N-NaOH, and 1% sucrose and licorice extract were added to the crude enzyme solution prepared by adding 0.02% of sodium azide. GTase activity was determined by measuring the degree of inhibition of glucan production relative to the no additive group without licorice extract by measuring turbidity at 660nm after adding at ppm, 50 ppm and 100 ppm concentration and reacting at 37 ℃ for 24 hours. Inhibitory effect was compared.
표 3에서 알 수 있듯이 감초추출물을 25 ppm 농도로 첨가하여도 충치균의 GTase의 활성이 현저히 저하되었으며 이와 같은 결과는 감초추출물이 충치균의 생육을 억제시킬 뿐만 아니라 GTase의 활성도 강력히 저하시키는 기능을 가지고 있음을 보여준다.As shown in Table 3, the addition of licorice extract at a concentration of 25 ppm significantly reduced the GTase activity of the cavities. The results showed that licorice extract not only inhibited the growth of cavities but also strongly reduced the activity of GTase. Shows.
표 3. 감초추출물의 GTase활성 저해 효과Table 3. Inhibitory Effect of Licorice Extract on GTase Activity
<시험예 4><Test Example 4>
상기 실시예의 방법에 의해 제조한 감초추출물 분말을 기존의 치약에 대하여0.025%, 0.05%, 0.1%에 해당하는 양을 첨가한 후 충치균에 대한 생육저해효과를 스트렙토코커스 뮤탄스 KFRI 1171 배양액 0.1㎖를 멸균된 BHI agar에 도말하고, 그 위에 종이 디스크(지름 8mm)를 놓아 추출물을 50㎕씩 흡수시키고 37℃에서 24시간 배양시키는 방법으로 살펴본 결과(도 4 참조), 감초추출물을 0.05% 이상 첨가하였을 때 뚜렷한 생육저해효과가 관찰되었다.The licorice extract powder prepared by the method of the above example was added to an amount corresponding to 0.025%, 0.05%, and 0.1% of the existing toothpaste, and then the growth inhibitory effect on the caries was confirmed by Streptococcus mutans. 0.1 ml of KFRI 1171 culture was smeared on sterilized BHI agar, and a paper disc (diameter 8 mm) was placed thereon to absorb 50 µl of the extract and incubate at 37 ° C. for 24 hours (see FIG. 4). When 0.05% or more was added, a marked growth inhibition effect was observed.
<시험예 5><Test Example 5>
상기 실시예 1의 방법에 의해 제조한 감초추출물 분말을 기존의 껌에 대하여 1.0%, 2.0%, 3.0%에 해당하는 양을 첨가하였을 때, 충치균인 스트렙토코커스 뮤탄스 KFRI 1171배양액 0.1㎖를 멸균된 BHI agar에 도말하고, 그 위에 종이 디스크(지름 8mm)를 놓아 추출물을 50㎕씩 흡수시키고 37℃에서 24시간 배양시키는 방법으로 살펴본 결과(도 5 참조), 감초추출물을 1.0% 이상 첨가하였을 때 뚜렷한 생육저해효과가 관찰되었다.When the licorice extract powder prepared by the method of Example 1 is added in an amount corresponding to 1.0%, 2.0%, and 3.0% with respect to the existing gum, Streptococcus mutans which is a decayed fungus 0.1 ml of KFRI 1171 culture solution was smeared on sterilized BHI agar, placed on a paper disc (8 mm in diameter), and 50 µl of the extract was absorbed and incubated at 37 ° C. for 24 hours. As a result (see FIG. 5), when the licorice extract was added more than 1.0%, a distinct growth inhibition effect was observed.
상기 시험예의 결과에서와 같이 본 발명에 의해 제조된 감초추출물은 우수한 충치균 생육억제 효과와 GTase 활성저해효과를 가지고 있었으며 본 발명에 의한 감초추출물을 치약, 껌, 사탕 등의 가공식품에 첨가함으로써 충치를 억제할 수 있는 식품의 공급이 가능하여 소비자들이 충치에 대한 부담이 없이 음식을 섭취할 수 있다. 또한 본 발명에 의한 감초추출물을 구강치료에 사용할 수 있는 의료용 제재에첨가함으로써 충치를 억제할 수 있는 의료용 제재를 제공할 수 있다.The licorice extract prepared by the present invention as shown in the results of the test example had excellent growth inhibitory effect on caries and inhibitory effect on GTase activity, and the licorice extract according to the present invention was added to processed foods such as toothpaste, gum and candy. It is possible to supply food that can be curtailed so that consumers can eat without burdening tooth decay. In addition, by adding the licorice extract according to the present invention to a medical preparation that can be used for oral treatment can provide a medical preparation that can suppress tooth decay.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0000653A KR100454226B1 (en) | 2001-01-05 | 2001-01-05 | Processing method of licorice extract and its' utilization on developing anti-cariogenic products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0000653A KR100454226B1 (en) | 2001-01-05 | 2001-01-05 | Processing method of licorice extract and its' utilization on developing anti-cariogenic products |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020057558A KR20020057558A (en) | 2002-07-11 |
KR100454226B1 true KR100454226B1 (en) | 2004-10-26 |
Family
ID=27690907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0000653A KR100454226B1 (en) | 2001-01-05 | 2001-01-05 | Processing method of licorice extract and its' utilization on developing anti-cariogenic products |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100454226B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010120005A1 (en) * | 2009-04-13 | 2010-10-21 | 주식회사 닥터 앤 푸드 | Method for extracting antibiotic materials from licorice and licorice extracts obtained by the method for cavity prevention |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100877009B1 (en) * | 2001-11-16 | 2009-01-07 | 서경훈 | The use of glycyrrhiza uralensis which increases the expression of protein disulfide isomerase |
KR20030093886A (en) * | 2002-06-05 | 2003-12-11 | 김영진 | Natural Herb Toothpaste |
WO2011129495A1 (en) * | 2010-04-16 | 2011-10-20 | Kim Hyoung Jun | Method for extracting an anticaries substance from licorice |
KR101007869B1 (en) * | 2010-07-15 | 2011-01-14 | 주식회사 에스앤텍 | The manufacturing method of water soluble licorice extract which has excellent food keeping activity |
KR101372458B1 (en) * | 2011-03-22 | 2014-03-11 | (주)애드바이오텍 | Extraction of functional components from Glycyrrhiza inflata and use of its extract |
WO2016122262A1 (en) * | 2015-01-29 | 2016-08-04 | 주식회사 덴트화이트 | Method for preparing licorice extract, and composition for preventing or treating oral diseases comprising extract obtained therefrom |
KR20220074419A (en) | 2020-11-27 | 2022-06-03 | 주식회사 더스푼 | Milk tea comprised of ricolice with low lactose which is prepared through treatment of lactase process at a low temperature |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3806617A (en) * | 1971-11-24 | 1974-04-23 | Y & S Candies Inc | Process for preparing licorice type candy |
US5156865A (en) * | 1991-08-16 | 1992-10-20 | Wm. Wrigley Jr. Company | Method of adding licorice to chewing gum |
JPH06157259A (en) * | 1992-08-26 | 1994-06-03 | Kanpou Iyaku Kenkyu Shinko Zaidan | Composition for oral cavity |
JPH07157417A (en) * | 1993-12-03 | 1995-06-20 | Nippon Flour Mills Co Ltd | Dentifrice composition |
KR950024754A (en) * | 1994-02-24 | 1995-09-15 | 백윤만 | Manufacturing method of dry toothpaste |
KR19980085158A (en) * | 1997-05-28 | 1998-12-05 | 이두호 | Gum with licorice |
-
2001
- 2001-01-05 KR KR10-2001-0000653A patent/KR100454226B1/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3806617A (en) * | 1971-11-24 | 1974-04-23 | Y & S Candies Inc | Process for preparing licorice type candy |
US5156865A (en) * | 1991-08-16 | 1992-10-20 | Wm. Wrigley Jr. Company | Method of adding licorice to chewing gum |
JPH06157259A (en) * | 1992-08-26 | 1994-06-03 | Kanpou Iyaku Kenkyu Shinko Zaidan | Composition for oral cavity |
JPH07157417A (en) * | 1993-12-03 | 1995-06-20 | Nippon Flour Mills Co Ltd | Dentifrice composition |
KR950024754A (en) * | 1994-02-24 | 1995-09-15 | 백윤만 | Manufacturing method of dry toothpaste |
KR19980085158A (en) * | 1997-05-28 | 1998-12-05 | 이두호 | Gum with licorice |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010120005A1 (en) * | 2009-04-13 | 2010-10-21 | 주식회사 닥터 앤 푸드 | Method for extracting antibiotic materials from licorice and licorice extracts obtained by the method for cavity prevention |
Also Published As
Publication number | Publication date |
---|---|
KR20020057558A (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101918266B1 (en) | The Extracting Method of Active Protein | |
KR101937345B1 (en) | A composition for anti-bacterial effect and anti-inflammation comprising unripe apple extracts and baicalin | |
JP6514684B2 (en) | Oral bacterial growth inhibitor | |
KR100454226B1 (en) | Processing method of licorice extract and its' utilization on developing anti-cariogenic products | |
JP4630416B2 (en) | Anti-caries, periodontal disease agent | |
KR20200029187A (en) | Composition with antibacterial effect on oral bacteria containing coffee extract, prebiotic, or coffee extract and prebiotic | |
JP3837172B2 (en) | Inhibitor of adhesion to periodontal tissue of Porphyromonas gingivalis containing high molecular weight polyphenol as an active ingredient | |
JPH09295944A (en) | Anticariogenic material, its production and use | |
AU2003289063B2 (en) | Process for producing hop glume polyphenol | |
KR102488050B1 (en) | Antibacterial composition comprising lactobacillus strain culture filtrate | |
KR102431182B1 (en) | Oral composition comprising fermented green tea extract having excellent antibacterial effect on oral bacteria and anti-inflammatory effect | |
KR101107237B1 (en) | Method for removing glycyrrhizin of liquorice, liquorice extract removed glycyrrhizin and method for manufacturing the same, and anti-cariogenic composition | |
KR101761771B1 (en) | Method for fermenting Broussonetia plant or the extract thereof, the fermented extracts thereby and the cosmetic composition containing the same | |
KR101929115B1 (en) | Composition for Preventing Biofilm Formation Containing Extract of Licorice and Extract of Rasberry | |
KR101644607B1 (en) | Compositions for Preventing or Treating for Diseases Derived from Helicobacter pylori comprising Extract of Black Rice and Health Food thereof | |
Sakanaka | Green tea polyphenols for prevention of dental caries | |
KR101875191B1 (en) | Composition for mouth comprising tengcha | |
KR20180114783A (en) | Composition for improving skin beauty comprising extract of fermented soybean fermented with Aspergillus cristatus strain | |
KR101506995B1 (en) | Anticariogenic composition comprising extract of bark of alnus japonica (thunberg) steudel | |
KR101929565B1 (en) | Composition for Preventing Biofilm Formation Containing Extract of Raspberry | |
KR100296775B1 (en) | Caries and cavities-inducing enzyme inhibitors and oral compositions containing them | |
KR102293400B1 (en) | Composition for eradicating Korean Helicobacter pylori and its use | |
KR101723103B1 (en) | A composition comprising fermented artemisia annua extract and fermented red ginseng concentrated powder for preventing, improving or treating inflammation induced virulence of oral bacteria | |
JPH03284625A (en) | Production of cariostatic substance and use thereof | |
KR20090088166A (en) | Process for xanthorrizole from curcuma xanthorriza and antibacterial activity material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121005 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20131008 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20141002 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20151015 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20161213 Year of fee payment: 13 |
|
LAPS | Lapse due to unpaid annual fee |